ArticleScience advances2022

Targeting oxidized phospholipids by AAV-based gene therapy in mice with established hepatic steatosis prevents progression to fibrosis.

Clint M Upchurch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.